Literature DB >> 14616696

The multiple roles of Fas ligand in the pathogenesis of infectious diseases.

D H Dockrell1.   

Abstract

Fas ligand (FasL) is a type II transmembrane protein that plays a critical role in immune homeostasis by binding to its receptor Fas (CD95) and inducing apoptosis. Fas/FasL dysregulation contributes to infectious disease pathogenesis. Microorganisms may inhibit Fas signal transduction to prolong intracellular survival and prevent killing by immune effector cells. FasL may be upregulated in directly infected cells to enhance killing of responding immune cells and facilitate immune evasion. The host response to infection may aim to induce apoptosis in directly infected cells, but immune cells that target directly infected cells can induce Fas-mediated apoptosis of uninfected bystander cells. FasL also contributes to the generation and regulation of the inflammatory response in infection. The multiple roles of FasL in infectious disease pathogenesis are discussed in the context of viral, bacterial and parasitic infections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616696     DOI: 10.1046/j.1469-0691.2003.00669.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  13 in total

1.  Streptococcal pyrogenic exotoxin B-induced apoptosis in A549 cells is mediated through alpha(v)beta(3) integrin and Fas.

Authors:  Wan-Hua Tsai; Chia-Wen Chang; Yee-Shin Lin; Woei-Jer Chuang; Jiunn-Jong Wu; Ching-Chuan Liu; Pei-Jane Tsai; Ming T Lin
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

Review 2.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

3.  Role of sialidase in Mycoplasma alligatoris-induced pulmonary fibroblast apoptosis.

Authors:  Marguerite E Hunt; Daniel R Brown
Journal:  Vet Microbiol       Date:  2006-10-17       Impact factor: 3.293

Review 4.  Clostridium difficile infection in patients with HIV/AIDS.

Authors:  Paul J Collini; Ed Kuijper; David H Dockrell
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

5.  Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.

Authors:  M Guzmán-Fulgencio; J Berenguer; M García-Álvarez; D Micheloud; J C López; J Cosín; I Fernández de Castro; P Catalán; P Miralles; S Resino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-03-26       Impact factor: 3.267

6.  Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.

Authors:  Hee Sup Kim; Eun Hwa Choi; Javed Khan; Emmanuel Roilides; Andrea Francesconi; Miki Kasai; Tin Sein; Robert L Schaufele; Kenichi Sakurai; Chang Gue Son; Braden T Greer; Stephen Chanock; Caron A Lyman; Thomas J Walsh
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 7.  The effector T cell response to influenza infection.

Authors:  Matthew M Hufford; Taeg S Kim; Jie Sun; Thomas J Braciale
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

8.  Fas/CD95-mediated apoptosis of type II cells is blocked by Toxoplasma gondii primarily via interference with the mitochondrial amplification loop.

Authors:  Diana Hippe; Oleksandr Lytovchenko; Ingo Schmitz; Carsten G K Lüder
Journal:  Infect Immun       Date:  2008-04-14       Impact factor: 3.441

9.  Galactoxylomannan-mediated immunological paralysis results from specific B cell depletion in the context of widespread immune system damage.

Authors:  Magdia De Jesus; André Moraes Nicola; Susana Frases; Ian R Lee; Steven Mieses; Arturo Casadevall
Journal:  J Immunol       Date:  2009-08-14       Impact factor: 5.422

10.  Mycobacterium tuberculosis nuoG is a virulence gene that inhibits apoptosis of infected host cells.

Authors:  Kamalakannan Velmurugan; Bing Chen; Jessica L Miller; Sharon Azogue; Serdar Gurses; Tsungda Hsu; Michael Glickman; William R Jacobs; Steven A Porcelli; Volker Briken
Journal:  PLoS Pathog       Date:  2007-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.